Salzman & Co’s UnitedHealth UNH Stock Holding History

Salzman & Co’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,150	Closed	-$2.03M	–	6
2020 Q1	$2.03M	Buy	+8,150	New	+$2.24M	6.84%	6

Other funds holding UNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Salzman & Co's UNH Position: Q2 2020 in Review

Salzman & Co sold out of UnitedHealth (UNH) in Q2 2020, closing a stake of 8,150 shares — an estimated $2.03M sold.

Salzman & Co first reported a position in UNH in Q1 2020 and held it in 1 quarter. The position peaked at $2.03M in Q1 2020. 2,208 funds tracked by Wall St. Rank hold UNH as of Q2 2020.

Salzman & Co reported no remaining UnitedHealth position as of Q2 2020 after selling out during the quarter.
Salzman & Co sold 8,150 UnitedHealth shares in Q2 2020, an estimated $2.03M.
Salzman & Co first reported a position in UnitedHealth in Q1 2020 and held it in 1 quarter.
Salzman & Co's UnitedHealth position peaked at $2.03M in Q1 2020.
2,208 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2020.

Based on Salzman & Co's 13F filing for Q2 2020.